AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Biopsy

Showing 11 to 20 of 425 articles

Clear Filters

Self-Supervised Learning for Feature Extraction from Glomerular Images and Disease Classification with Minimal Annotations.

Journal of the American Society of Nephrology : JASN
BACKGROUND: Deep learning has great potential in digital kidney pathology. However, its effectiveness depends heavily on the availability of extensively labeled datasets, which are often limited because of the specialized knowledge and time required ...

Multimodal Artificial Intelligence-Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology-Positive Gastric Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Gastric cancer with peritoneal dissemination remains a significant clinical challenge due to its poor prognosis and difficulty in early detection. This study introduces a multimodal artificial intelligence-based risk stratification assessment (RSA) m...

Artificial intelligence challenge of discriminating cutaneous arteritis and polyarteritis nodosa based on hematoxylin-and-eosin images of skin biopsy specimens.

Pathology, research and practice
Diseases that develop necrotizing vasculitis of cutaneous muscular arteries include cutaneous arteritis (CA) and polyarteritis nodosa (PAN). It is difficult to distinguish them based on skin biopsy findings alone. This study demonstrated that artific...

Complex wound analysis using AI.

Computers in biology and medicine
Impaired wound healing is a significant clinical challenge. Standard wound analysis approaches are macroscopic, with limited histological assessments that rely on visual inspection of haematoxylin and eosin (H&E)-stained sections of biopsies. The ana...

Assessing the performance of an artificial intelligence based chatbot in the differential diagnosis of oral mucosal lesions: clinical validation study.

Clinical oral investigations
OBJECTIVES: Artificial intelligence (AI) is becoming more popular in medicine. The current study aims to investigate, primarily, if an AI-based chatbot, such as ChatGPT, could be a valid tool for assisting in establishing a differential diagnosis of ...

Prediction of prostate biopsy outcomes at different cut-offs of prostate-specific antigen using machine learning: a multicenter study.

Journal of the Egyptian National Cancer Institute
BACKGROUND: Machine learning (ML) is a significant area of artificial intelligence, which can improve the accuracy of predictive or diagnostic models for differentiating between prostate biopsy outcomes. This study aims to develop a novel decision-su...

Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States.

BMC health services research
OBJECTIVES: Novel non-invasive machine learning algorithms may improve accuracy and reduce the need for biopsy when diagnosing idiopathic pulmonary fibrosis (IPF). We conducted a cost-effectiveness analysis of diagnostic strategies for IPF.

Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study.

World journal of gastroenterology
BACKGROUND: The global prevalence of non-alcoholic steatohepatitis (NASH) and its associated risk of adverse outcomes, particularly in patients with advanced liver fibrosis, underscores the importance of early and accurate diagnosis.

Development of a deep learning-based model to evaluate changes during radiotherapy using cervical cancer digital pathology.

Journal of radiation research
This study aims to create a deep learning-based classification model for cervical cancer biopsy before and during radiotherapy, visualize the results on whole slide images (WSIs), and explore the clinical significance of obtained features. This study...

Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy.

Clinical cancer research : an official journal of the American Association for Cancer Research
PURPOSE: A multimodal artificial intelligence (MMAI) biomarker was developed using clinical trial data from North American men with localized prostate cancer treated with definitive radiation, using biopsy digital pathology images and key clinical in...